ABBVIE A/S: Financial statements 2017
CVR: 34462828
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ABBVIE A/S (CVR 34462828) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 553,888,872 and a net result of DKK 20,902,364 compared with DKK 26,255,288 the year before. That is an increase of 2.3% compared with the year before. The profit margin was 3.8%. Equity in the 2017 report amounted to DKK 119,790,837. The solvency ratio was 56.9%. The company had 78 employees in the financial year.
- Revenue
- DKK 553,888,872
- Gross Profit
- DKK 123,682,689
- Profit/Loss
- DKK 20,902,364
- Equity
- DKK 119,790,837
- Total Assets
- DKK 210,474,773
- Employees
- 78
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 553.9 mio. | 123.7 mio. | 20.9 mio. | 119.8 mio. | 78 |
| 2016 | 541.4 mio. | 123.2 mio. | 26.3 mio. | 118.9 mio. | 84 |
| 2015 | 568.2 mio. | 131.8 mio. | 21.5 mio. | 92.6 mio. | 96 |
| 2014 | 535.8 mio. | 114.2 mio. | 13.1 mio. | 71.1 mio. | 94 |
| 2013 | 525.5 mio. | 93.9 mio. | 10.6 mio. | 58 mio. | 83 |
Official annual report
Keep an eye on ABBVIE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ABBVIE A/S has published its annual report for 2016. Revenue came to DKK 541,398,058, and the net result was DKK 26,255,288.
About ABBVIE A/S
ABBVIE A/S is a Danish company of the type Aktieselskab based in København N, founded in 2012. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named WCA PHARMACEUTICALS A/S. The management consists of Thea Larsen. The board consists of Matthew Robert Iles (chair), Arnaud Jean Jacques Coint-Bavarot, Jens Lange and Shitra Irari Amozurrutia Blancas. The company is owned by AbbVie Central Finance B.V.. The company has 59 employees (2026). In 2025, the company reported revenue of DKK 472,957,984 and a net result of DKK 25,023,523 compared with DKK 11,055,919 the year before. Equity in the 2025 report amounted to DKK 98,011,918.